Yahoo Web Search

Search results

1. 

2. People also ask

   Which masks are best for air travel?
   Which colleges are removing booster mandate?
   How to get over COVID faster?
   How to treat COVID at home?
   Which OTC medications work best on Omicron variants?

3. www.ncbi.nlm.nih.gov › pmc › articlesAntibiotics Use in COVID-19 Patients: A Systematic Literature...

   www.ncbi.nlm.nih.gov › pmc › articles

   Dec 4, 2022 · Five-hundred-ninety-three studies were identified, published from January 2020 to 30 October 2022. Thirty-six studies were included in this systematic review. Of the 36 included studies, 32 studies were on the use of antibiotics in COVID-19 inpatients and 4 on antibiotic use in COVID-19 outpatients.

   • Table 4

     Antibiotic therapy not recommended in patients with mild...

   • Open in a Separate Window

     925 COVID-19 patients. All the hospital wards: Sputum, blood...

   • Antibiotics for the treatment

     The use of antibiotics follows the intention-to-treat the...

4. www.aafp.org › pubs › afpAntibiotics for the Treatment of COVID-19 | AAFP

   www.aafp.org › pubs › afp

   • Cached

   Azithromycin (Zithromax) is the most consistently studied antibiotic for use in treating patients infected with the SARS-CoV-2 virus; it does not improve mortality after 28 days or affect the...

5. www.ncbi.nlm.nih.gov › pmc › articlesAntibiotics in treatment of COVID-19 complications: a review ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Feb 9, 2021 · Patients’ characteristics, clinical outcomes, as well as selected characteristics regarding antibiotic use (indication, class used, rates and types of bacterial secondary and co-infection, and duration of treatment) were analyzed. Results. Nineteen clinical studies reporting data from 2834 patients were included.

   • Author: Marie Chedid, Rami Waked, Elie Haddad, Nabil Chetata, Gebrael Saliba, Jacques Choucair
   • DOI: 10.1016/j.jiph.2021.02.001

   • Publish Year: 2021
   • Published: 2021/05

6. www.ncbi.nlm.nih.gov › pmc › articlesThe use of antibiotics in COVID-19 management: a rapid review ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jun 23, 2021 · Our findings revealed that various antibiotics, such as azithromycin, doxycycline, clarithromycin, ceftriaxone, erythromycin, amoxicillin, amoxicillin-clavulanic acid, ampicillin, gentamicin, benzylpenicillin, piperacillin/tazobactam, ciprofloxacin, ceftazidime, cefepime, vancomycin, meropenem, and cefuroxime among others, were recommended for u...

   • Author: Yusuff Adebayo Adebisi, Nafisat Dasola Jimoh, Isaac Olushola Ogunkola, Theogene Uwizeyimana, Alaka H...

   • Publish Year: 2021

7. pubmed.ncbi.nlm.nih.gov › 36498781Antibiotics Use in COVID-19 Patients: A Systematic ... - PubMed

   pubmed.ncbi.nlm.nih.gov › 36498781

   Dec 4, 2022 · Antibiotics should not be prescribed during COVID-19 unless there is a strong clinical suspicion of bacterial coinfection or superinfection.

8. www.ncbi.nlm.nih.gov › pmc › articlesWhen to Use Antibiotics in COVID-19: A Proposal Based on ...

   www.ncbi.nlm.nih.gov › pmc › articles

   Jul 28, 2022 · Even though COVID-19 is a viral disease, the frequent use of antibacterial agents for its treatment is a concern [ 1 ]. During the initial stages of the pandemic, there was an indiscriminate use of these agents based on the fact that viral respiratory infections predispose to bacterial superinfection [ 1 ].